Full-Time

Finance Business Partner R&D

IT and Product, Malvern, PA

Posted on 10/4/2025

Philips

Philips

Manufactures sleep therapy and respiratory devices

Compensation Overview

$116k - $185k/yr

+ Annual incentive bonus + Sales commission + Long-term incentives

No H1B Sponsorship

Malvern, PA, USA

Hybrid

On-site at least 3 days per week; Malvern, PA office.

Category
Finance & Banking (3)
, ,
Requirements
  • 5+ years of experience with Bachelor's OR Minimum 3 years of experience with Master's in areas such as Business Partnering, Corporate Finance, Financial Planning and Analysis (FP&A), R&D Finance, IT Finance, or equivalent. Experience with capital allocation and investment analysis in a technology-driven environment is highly preferred.
  • Your skills include financial modeling—particularly for R&D, IT, and capital investment alongside strong capabilities in Financial Planning and Analysis (FP&A), forecasting innovation spend and ROI, and capital allocation.
  • Your expertise spans budget management for R&D and IT, a deep understanding of software and hardware development cost structures, and hands-on experience supporting SAP and Windchill implementations.
  • Bachelor's / Master's Degree in Finance, Economics, Business Administration, Accounting or equivalent.
  • You must be able to successfully perform the following minimum Physical, Cognitive and Environmental job requirements with or without accommodation for this position (as described in the link).
  • You’re a strong communicator who works effectively across a matrix organization.  You are a trusted partner to stakeholders across R&D, IT, Product, and executive leadership, known for your commercial acumen, ability to challenge and influence at all levels, and your strong analytical, communication, and presentation skills. Your documentation and reporting proficiency ensures clarity and alignment across financial initiatives.
  • US work authorization is a precondition of employment. The company will not consider candidates who require sponsorship for a work-authorized visa.
Responsibilities
  • Acts as a financial SME for R&D, IT, and Product innovation, leading capital allocation and business case development to maximize ROI. Partners with senior leaders to embed financial insights into strategic decisions, identify risks and opportunities, and drive accountability. Supports efforts to reduce operational spending and redirect resources toward high-impact innovation.
  • Operates with limited supervision to shape and execute financial policies impacting R&D, IT, and Product functions, while contributing to broader investment strategies. Drives continuous improvement of financial tools and processes, leading cross-functional initiatives to enhance planning accuracy and strategic alignment. Delivers high-level financial presentations on investment performance and ROI to executive leadership, translating complex data into clear insights. Monitors detailed financial performance, identifying trends and partnering with leaders to optimize outcomes.
  • Ensures financial practices across R&D, IT, and Product meet the highest standards of integrity, compliance, and governance, while proactively identifying areas for improvement. Mentors junior finance team members, sharing expertise in analysis, strategic thinking, and business partnering within innovation-driven environments. Leads or supports cross-functional initiatives involving product development, system implementations, and software/hardware integration, ensuring financial goals are embedded in broader strategies. Provides financial oversight during enterprise system rollouts like SAP and Windchill, supporting successful adoption and benefits realization.
Desired Qualifications
  • Strong communication and collaboration skills across a matrix organization; trusted partner to stakeholders across R&D, IT, Product, and executive leadership, with commercial acumen and ability to challenge and influence at all levels, and strong analytical, communication, and presentation skills.
  • Experience with SAP and Windchill implementations.
  • Experience in capital allocation and investment analysis in a technology-driven environment is highly preferred.
  • Proven ability to mentor junior finance team members and lead cross-functional initiatives in innovation-driven environments.

Philips Respironics designs sleep and respiratory care devices, including CPAP and BiPAP machines, ventilators, and oxygen concentrators, plus related systems. These devices deliver regulated air pressure, support or assist breathing, and provide concentrated oxygen, often paired with software and data tools for monitoring. The division differentiates itself through its long history within Philips and its integrated ecosystem that connects devices with analytics and clinical support across hospital, clinic, and home settings. Its goal is to improve quality of life and clinical outcomes for people with sleep and respiratory conditions by offering reliable devices, patient support, and data-driven care.

Company Size

N/A

Company Stage

Acquired

Total Funding

$5.1B

Headquarters

Murrysville, Pennsylvania

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • BioTelemetry acquisition in 2020 expands remote heart monitoring.
  • $479 million settlement in September 2023 closes US litigation.
  • New silicone foam validated safe, enabling global device sales.

What critics are saying

  • ResMed seizes US sleep market share within 6-12 months.
  • FDA consent decree blocks US sales until after 2026.
  • January 2024 US ventilation exit halves revenue permanently.

What makes Philips unique

  • Pioneered CPAP therapy as standard for sleep apnea since 1976.
  • Leads in non-invasive ventilation and home respiratory support.
  • Integrates devices with software for data-driven clinical outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Health Savings Account/Flexible Spending Account

Company News

HIT Consultant
Apr 12th, 2024
Philips Respironics Reaches Final Agreement With Us Regulators On Sleep Apnea Device Recall

<img src="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp" alt="Philips Respironics Reaches Final Agreement with US Regulators on Sleep Apnea Device Recall. " class="wp-image-78777" srcset="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp 700w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-300x161.webp 300w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-290x155.webp 290w" sizes="(max-width: 700px) 100vw, 700px">What You Should Know: – Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during a 2021 inspection of a Philips facility in Pennsylvania.– The agreement focuses on Philips Respironics’ operations in the US, particularly regarding the recall of certain sleep and respiratory care devices.– The company’s focus will now be on completing remediation efforts, ensuring patient safety, and regaining regulatory approval to resume sales of new devices in the US.Focus on Remediation and ComplianceThe consent decree outlines a roadmap for Philips Respironics to:Prioritize Recall Remediation: Philips will continue efforts to remediate millions of sleep apnea and respiratory care devices recalled in June 2021 due to potential health risks associated with degraded sound abatement foam.Independent Oversight: Independent experts will be brought in to review recall remediation efforts and ensure Philips Respironics’ business operations comply with FDA regulations.Continued Patient Support: Philips Respironics can continue servicing existing devices in the hands of patients and healthcare providers. Additionally, they can sell accessories, consumables, and replacement parts for these devices.Sales Restrictions Remain in USThe FDA has not yet authorized Philips Respironics to resume sales of new CPAP, BiPAP, or other respiratory care devices in the US. This restriction will remain in place until Philips meets the requirements outlined in the consent decree.Global Sales Continue with RestrictionsPhilips Respironics can continue to sell new devices, accessories, consumables, and replacement parts outside the US,  subject to specific requirements.Safety of Devices with New Foam ConfirmedPhilips Respironics has conducted tests on devices using a new silicone sound abatement foam and found no safety issues. Patients can continue to use these devices following the instructions for use.Financial ImpactPhilips anticipates incurring costs associated with remediation activities and profit disgorgement related to US sales. These costs are estimated at 100 basis points in 2024.  The company’s previously announced 2023-2025 financial outlook remains unchanged,  already factoring in the consent decree. “Strengthening patient safety and quality remains Philips’ highest priority and the increased scrutiny will help us to improve even more

Goodrich Pharmacy
Jan 29th, 2024
Phillips Suspends U.S. Sales of CPAP, Ventilator Machines After Recall

Following a recall of millions of its breathing machines that began in mid-2021, Phillips Respironics announced Monday that it would halt sales of all such machines within the United States.

Parker Waichman LLP
Mar 23rd, 2023
Sleep Apnea Patients Suffer While Waiting To Receive Their Repaired Philips CPAP Machines

In June of 2021, Philips began a recall of over five million of its breathing devices due to toxic fume and substances emanating from the devices’ sound abatement foam.

Digital Journal
Jan 13th, 2023
Ultrasound Market Share | Market | Report | Analysis 2032 | Key Players: Fujifilm Holdings Corporation, Analogic Corporation, Siemens Healthcare among others

February 2019 – Koninklijke Philips launched the EPIQ Elite ultrasound system in the market.

VentureBeat
Oct 26th, 2022
Philips Norelco Brings Movember To Roblox With Shavetopia

Register now for your free virtual pass to the Low-Code/No-Code Summit this November 9. Hear from executives from Service Now, Credit Karma, Stitch Fix, Appian, and more. Learn more. Philips Norelco is creating an interactive metaverse experience called Shavetopia in Roblox, based around the Movember trend. For anyone who doesn’t know what that is, Movember is where people grow facial hair for the entire month of November. The portmanteau comes from adding the word mustache to the name of the month

INACTIVE